Unmet : Actualité Unmet en direct - P2 | Bourse Reflex
Accueil > Tags > Unmet

  • Toutes les actualités en rapport avec « Unmet »

24/03 07:30 Unmet - Quantum Genomics Raises EUR 8.6 Million in U.S. and Europe

03/02 18:30 Unmet - Quantum Genomics Expands U.S. Presence to Advance its Development Programs for Cardiovascular Diseases

20/01 18:00 Unmet - Enhancement of Quantum Genomics' intellectual property

05/01 18:00 Unmet - Patient enrolment 100% completed for Phase IIa trial for high blood pressure

16/12 18:00 Unmet - Further advance for Quantum Genomics in securing animal health partnership for heart failure treatment

15/10 19:15 Unmet - 2015 Half-year results - Update on latest developments

06/10 18:00 Unmet - Positive opinion from Monitoring Board to continue protocol as planned, for Phase IIa clinical trial under way for high blood pressure

22/09 18:00 Unmet - Quantum Genomics to meet investors at the European Large and Midcap Event, October 7 and 8, 2015

08/09 18:00 Unmet - Phase IIa clinical trial for high blood pressure : 50% enrolment four months ahead of schedule and Supervisory Board meeting coming up

24/08 18:00 Unmet - Disclosure of the total number of voting rights and the number of shares of the share capital

27/07 18:00 Unmet - Quantum Genomics announces the appointment of Professor Faiez Zannad as its heart failure consultant

07/07 18:00 Unmet - Independent Data Safety Monitoring Board Recommends Continuation per Protocol of Genticel's Phase 2 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

02/07 08:00 Unmet - Quantum Genomics speeds its development work in the field of heart failure

29/06 18:45 Unmet - Quantum Genomics obtains positive results with heart failure study in dogs

16/06 07:00 Unmet - Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

02/06 17:45 Unmet - Quantum Genomics at the 2015 BIO International Convention, June 15-18 in Philadelphia, and at the French Life Sciences Days, June 17-18, 2015, in New York

01/06 07:00 Unmet - Genticel Announces Positive Preclinical Proof of Concept Results of GTL002, its New Multivalent HPV Therapeutic Vaccine Candidate Based on Company's Versatile Vaxiclase Platform

22/04 18:45 Unmet - 2014 Annual financial report now available - Update on Q1 2015 activity

22/04 18:30 Unmet - 2014 Annual financial report now available - Update on Q1 2015 activity

16/04 17:45 Unmet - Quantum Genomics to meet investors at the European Smallcap Event, April 27 and 28, 2015